Nanopharmaceutical-based regenerative medicine: a promising therapeutic strategy for spinal cord injury-Reference-Cited by-同舟云学术

Nanopharmaceutical-based regenerative medicine: a promising therapeutic strategy for spinal cord injury

Published:2021 Issue:10 Volume:9 Page:2367-2383
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Zhao Chen¹²³⁴⁵,Xing Zheng¹²³⁴⁵,Zhang Chunchen⁶⁷⁸⁹¹⁰,Fan Yubo¹²³⁴⁵,Liu Haifeng¹²³⁴⁵^ORCID

Affiliation:

1. Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education

2. Beijing Advanced Innovation Centre for Biomedical Engineering

3. School of Biological Science and Medical Engineering

4. Beihang University

5. Beijing, 100191

6. Key Laboratory for Biomedical Engineering of Education Ministry of China

7. Zhejiang University

8. Hangzhou

9. P. R. China

10. Zhejiang Provincial Key Laboratory of Cardio-Cerebral Vascular Detection Technology and Medicinal Effectiveness Appraisal

Abstract

Spinal cord injury (SCI) is a severe neurological disease with unclear pathological mechanisms. This review summarizes and elaborates on the research progress as well as the challenges and future of nanopharmaceuticals in the treatment of SCI.

Funder

National Natural Science Foundation of China

Higher Education Discipline Innovation Project

Fundamental Research Funds for the Central Universities

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2021/TB/D0TB02740E

Reference190 articles.

1. Doxil® — The first FDA-approved nano-drug: Lessons learned

2. Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications

3. FDA, Journal, 2014

4. A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system

5. m6A facilitates hippocampus-dependent learning and memory through YTHDF1

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond the adverse effects of the systemic route: Exploiting nanocarriers for the topical treatment of skin cancers;Advanced Drug Delivery Reviews;2024-04

2. Biomaterials in Drug Delivery: Advancements in Cancer and Diverse Therapies—Review;International Journal of Molecular Sciences;2024-03-08

3. Nanotherapeutics for Alleviating Anesthesia‐Associated Complications;Advanced Science;2024-02-11

4. External magnetic field non-invasively stimulates spinal cord regeneration in rat via a magnetic-responsive aligned fibrin hydrogel;Biofabrication;2023-06-16

5. circ_0013613 Promotes the recovery of spinal cord injury by regulating mir-370-3p/caspase1 to regulate neuronal pyroptosis;Acta Biochimica Polonica;2023-02-03